Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 2 feeds behind: Insider filings, 5 days, and 1 more · Every feed →

All 11Congress 0Executive branch 0Insiders 11
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

ANTX · 11 trades

Trades
11
Buys 1 · Sells 10
People
4
Stocks
1
Disclosed value
$355K
range midpoints · Congress & executive
Filed late
2
  1. ▼ SELLRobin Shane Readnour DirectorANTX AN2 Therapeutics, Inc.$3.2Kdisclosed Sep 11 · filed 2 days after the trade
  2. ▼ SELLRobin Shane Readnour DirectorANTX AN2 Therapeutics, Inc.$3.5Kdisclosed Sep 11 · filed 2 days after the trade
  3. ▼ SELLRobin Shane Readnour DirectorANTX AN2 Therapeutics, Inc.$28.4Kdisclosed Sep 8 · filed the same day
  4. ▼ SELLRobin Shane Readnour DirectorANTX AN2 Therapeutics, Inc.$31.9Kdisclosed Sep 8 · filed the same day
  5. ▼ SELLRobin Shane Readnour DirectorANTX AN2 Therapeutics, Inc.$17.5Kdisclosed Sep 8 · filed 5 days after the trade · late
  6. ▼ SELLRobin Shane Readnour DirectorANTX AN2 Therapeutics, Inc.$19.6Kdisclosed Sep 8 · filed 5 days after the trade · late
  7. ▼ SELLSarah Joanne Williams Principal Accounting OfficerANTX AN2 Therapeutics, Inc.$1.5Kdisclosed Sep 4 · filed 3 days after the trade
  8. ▲ BUYMargaret M FitzPatrick DirectorANTX AN2 Therapeutics, Inc.$11.6Kdisclosed Sep 2 · filed 1 day after the trade
  9. ▼ SELLRobin Shane Readnour DirectorANTX AN2 Therapeutics, Inc.$112Kdisclosed Aug 19 · filed 2 days after the trade
  10. ▼ SELLRobin Shane Readnour DirectorANTX AN2 Therapeutics, Inc.$100Kdisclosed Aug 19 · filed 2 days after the trade
  11. ▼ SELLJoshua M Eizen InsiderANTX AN2 Therapeutics, Inc.$24.8Kdisclosed Jul 10 · filed 2 days after the trade